Vital USA Respiratory Rate Validation In Adults
RR
Final Test Report for Vital USA Respiratory Rate Validation In Adults
1 other identifier
interventional
20
1 country
1
Brief Summary
Vital USA is dedicated to developing and applying innovative electronic medical solutions that improve patient care in multiple clinical settings. Vital USA is a manufacturer of a multi-parameter patient monitor that is intended to be used in a variety of medical settings including hospitals, medical offices and patients' homes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 17, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2019
CompletedFirst Submitted
Initial submission to the registry
February 21, 2020
CompletedFirst Posted
Study publicly available on registry
March 3, 2020
CompletedResults Posted
Study results publicly available
May 28, 2020
CompletedMay 28, 2020
May 1, 2020
3 days
February 21, 2020
March 11, 2020
May 20, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Respiratory Rate Accuracy Validation for the Vital USA Vital Detect Monitor.
The primary objective of this study was to compare the accuracy of device under test for the measurement of respiratory rate. The respiratory rate was measured simultaneously with EtCO2 (Reference) and the Vital USA Vital Detect monitor (Device Under Test).The endpoint of interest was accuracy as measured by the Accuracy root-mean-square (ARMS) difference between the Device Under Test (DUT) and the reference respiratory rate system (Ref) for all stable respiratory periods.
20 Seconds
Study Arms (1)
Respiratory Rate
EXPERIMENTALThe purpose of this study is to conduct a Respiratory Rate accuracy validation comparing the Vital USA Vital Detect to an FDA cleared End Tidal Carbon Dioxide monitor Reference Standard (GE Datex-Ohmeda). This report documents exclusively the results of the Respiratory Rate accuracy performance for the Vital USA Vital Detect.
Interventions
The Vital Detect is a noninvasive device designed for spot-checking physiological parameters, such as Noninvasive Blood Pressure, Oxygen Saturation, Pulse Rate, Body Temperature, and Respiratory Rate. This device is a finger-cuff technology which is applicable for use at-home or in healthcare facilities in/on individuals 18 years of age and older. It may be used by the individual themselves or an operator. The Vital Detect is not intended for continuous monitoring or for use with high frequency surgical equipment. It is non transit-operable. The Vital USA Vital Detect is composed of a sensor head mounted on a base connected to a phone or computer via Vital Detect App which is free to download.
Eligibility Criteria
You may qualify if:
- Subject must have the ability to understand and provide written informed consent
- Subject is adult over 18 years of age
- Subject must be willing and able to comply with study procedures and duration
- Subject is a non-smoker
- Male or female of any race
You may not qualify if:
- Subject is considered as being morbidly obese (defined as BMI \>39.5)
- Compromised circulation, injury, or physical malformation of fingers, toes, hands, ears or forehead/skull or other sensor sites which would limit the ability to test sites needed for the study. (Note: Certain malformations may still allow subjects to participate if the condition is noted and would not affect the particular sites utilized.)
- Subjects with known respiratory conditions such as:
- uncontrolled / severe asthma,
- flu,
- pneumonia / bronchitis,
- shortness of breath / respiratory distress,
- respiratory or lung surgery,
- emphysema, COPD, lung disease
- Subjects with self-reported heart or cardiovascular conditions such as:
- have had cardiovascular surgery
- Chest pain (angina)
- heart rhythms other than a normal sinus rhythm or with respiratory sinus arrhythmia
- previous heart attack
- blocked artery
- +19 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Vital USA, Inc.lead
- Clinimark, LLCcollaborator
Study Sites (1)
Clinimark Laboratory Services
Louisville, Colorado, 80027, United States
Limitations and Caveats
There were no serious adverse events or serious adverse device effects during the study. There were no observed device deficiencies that could have led to serious adverse device effects.
Results Point of Contact
- Title
- Mark H Khachaturian, PhD
- Organization
- Vital USA Inc.
Study Officials
- PRINCIPAL INVESTIGATOR
Arthur Cabrera, MD
Clinimark, LLC
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 21, 2020
First Posted
March 3, 2020
Study Start
December 17, 2019
Primary Completion
December 20, 2019
Study Completion
December 20, 2019
Last Updated
May 28, 2020
Results First Posted
May 28, 2020
Record last verified: 2020-05
Data Sharing
- IPD Sharing
- Will not share